11/14
11:03 am
acrv
Rating for ACRV
Low
Report
Rating for ACRV
11/14
11:03 am
acrv
Rating for ACRV
Low
Report
Rating for ACRV
11/14
08:15 am
acrv
Acrivon Therapeutics, Inc. (NASDAQ: ACRV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Medium
Report
Acrivon Therapeutics, Inc. (NASDAQ: ACRV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.